Works by Tan, Antoinette

Results: 39

Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors.
Published in:
2016
By:
- Chow, Laura;
- Smith, David;
- Tan, Antoinette;
- Denlinger, Crystal;
- Wang, Ding;
- Shepard, Dale;
- Chaudhary, Archana;
- Lin, Yong;
- Gao, Ling;
- Chow, Laura Q M;
- Smith, David C;
- Tan, Antoinette R;
- Denlinger, Crystal S;
- Shepard, Dale R
Publication type:
journal article
Pharmacokinetics of eribulin mesylate in cancer patients with normal and impaired renal function.
Published in:
2015
By:
- Tan, Antoinette;
- Sarantopoulos, John;
- Lee, Lucy;
- Reyderman, Larisa;
- He, Yi;
- Olivo, Martin;
- Goel, Sanjay;
- Tan, Antoinette R
Publication type:
journal article
Phase I Study of Pazopanib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumors.
Published in:
Oncologist, 2010, v. 15, n. 12, p. 1253, doi. 10.1634/theoncologist.2010-0095
By:
- TAN, ANTOINETTE R.;
- DOWLATI, AFSHIN;
- JONES, SUZANNE F.;
- INFANTE, JEFFREY R.;
- NISHIOKA, JENNIFER;
- FANG, LEI;
- HODGE, JEFFREY P.;
- GAINER, SHELBY D.;
- ARUMUGHAM, THANGAM;
- SUTTLE, A. BENJAMIN;
- DAR, MOHAMMED M.;
- LAGER, JOANNE J.;
- BURRIS III, HOWARD A.
Publication type:
Article
The current state of molecular testing in the treatment of patients with solid tumors, 2019.
Published in:
2019
By:
- El‐Deiry, Wafik S.;
- Goldberg, Richard M.;
- Lenz, Heinz‐Josef;
- Shields, Anthony F.;
- Gibney, Geoffrey T.;
- Tan, Antoinette R.;
- Brown, Jubilee;
- Eisenberg, Burton;
- Heath, Elisabeth I.;
- Phuphanich, Surasak;
- Kim, Edward;
- Brenner, Andrew J.;
- Marshall, John L.;
- El-Deiry, Wafik S;
- Lenz, Heinz-Josef
Publication type:
journal article
Modern Flat Panel Antenna Technology for Ku-/Ka-Band User Terminals in LEO Satellite Communications Systems.
Published in:
Microwave Journal, 2021, v. 64, n. 9, p. 70
By:
- Gupta, Utsav;
- Tan, Antoinette;
- Liu, James;
- Lohmeyer, Whitney
Publication type:
Article
The Genomic Landscape of Breast Cancer in Young and Older Women.
Published in:
Clinical Breast Cancer, 2024, v. 24, n. 7, p. 630, doi. 10.1016/j.clbc.2024.07.008
By:
- Heeke, Arielle L.;
- Wei Sha;
- Feldman, Rebecca;
- Fisher, Julie;
- Hadzikadic-Gusic, Lejla;
- Symanowski, James T.;
- White Jr, Richard L.;
- Tan, Antoinette R.
Publication type:
Article
Safety and pharmacokinetics of veliparib extended‐release in patients with advanced solid tumors: a phase I study.
Published in:
Cancer Medicine, 2018, v. 7, n. 6, p. 2360, doi. 10.1002/cam4.1488
By:
- Werner, Theresa L.;
- Sachdev, Jasgit;
- Swisher, Elizabeth M.;
- Gutierrez, Martin;
- Kittaneh, Muaiad;
- Stein, Mark N.;
- Xiong, Hao;
- Dunbar, Martin;
- Sullivan, Danielle;
- Komarnitsky, Philip;
- Mckee, Mark;
- Tan, Antoinette R.
Publication type:
Article
Trilaciclib: A First-in-class Therapy to Reduce Chemotherapy-induced Myelosuppression.
Published in:
touchREVIEWS in Oncology & Haematology, 2022, v. 18, n. 2, p. 152, doi. 10.17925/OHR.2022.18.2.152
By:
- Young, Joanna A.;
- Tan, Antoinette R.
Publication type:
Article
Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer.
Published in:
Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1235902
By:
- Sammons, Sarah;
- Elliott, Andrew;
- Barroso-Sousa, Romualdo;
- Chumsri, Saranya;
- Tan, Antoinette R.;
- Sledge Jr., George W.;
- Tolaney, Sara M.;
- Torres, Evanthia T. Roussos
Publication type:
Article
A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors.
Published in:
Cancer (0008543X), 2012, v. 118, n. 17, p. 4262, doi. 10.1002/cncr.27428
By:
- Rocha-Lima, Caio M.;
- Bayraktar, Soley;
- MacIntyre, Jessica;
- Raez, Luis;
- Flores, Aurea M.;
- Ferrell, Annapoorna;
- Rubin, Eric H.;
- Poplin, Elizabeth A.;
- Tan, Antoinette R.;
- Lucarelli, Antonio;
- Zojwalla, Naseem
Publication type:
Article
Checkpoint inhibitor therapy for metastatic triple-negative breast cancer.
Published in:
Cancer & Metastasis Reviews, 2021, v. 40, n. 2, p. 537, doi. 10.1007/s10555-021-09972-4
By:
- Heeke, Arielle L.;
- Tan, Antoinette R.
Publication type:
Article
Investigating potential immune mechanisms of trilaciclib administered prior to chemotherapy in patients with metastatic triple-negative breast cancer.
Published in:
Breast Cancer Research & Treatment, 2023, v. 201, n. 2, p. 307, doi. 10.1007/s10549-023-07009-8
By:
- Tan, Antoinette R.;
- O'Shaughnessy, Joyce;
- Cao, Subing;
- Ahn, Sarah;
- Yi, John S.
Publication type:
Article
The Evolving Role of Immune Checkpoint Inhibitors in the Treatment of Triple-Negative Breast Cancer.
Published in:
Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 5, p. 305
By:
- Steiner, Meghan;
- Tan, Antoinette R.
Publication type:
Article
Development of Poly(ADP-Ribose) Polymerase Inhibitors in the Treatment of BRCA-Mutated Breast Cancer.
Published in:
Clinical Advances in Hematology & Oncology, 2018, p. 491
By:
- Sulai, Nanna H.;
- Tan, Antoinette R.
Publication type:
Article
A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors.
Published in:
Investigational New Drugs, 2020, v. 38, n. 3, p. 855, doi. 10.1007/s10637-019-00807-2
By:
- Stein, Mark N.;
- Goodin, Susan;
- Gounder, Murugeson;
- Gibbon, Darlene;
- Moss, Rebecca;
- Portal, Daniella;
- Lindquist, Diana;
- Zhao, Yujie;
- Takebe, Naoko;
- Tan, Antoinette;
- Aisner, Joseph;
- Lin, Hongxia;
- Ready, Neal;
- Mehnert, Janice M.
Publication type:
Article
A phase I trial of MK-0731, a Kinesin Spindle Protein (KSP) inhibitor, in patients with solid tumors.
Published in:
Investigational New Drugs, 2012, v. 30, n. 3, p. 1088, doi. 10.1007/s10637-011-9653-1
By:
- Holen, Kyle;
- DiPaola, Robert;
- Liu, Glenn;
- Tan, Antoinette;
- Wilding, George;
- Hsu, Karl;
- Agrawal, Nancy;
- Chen, Cong;
- Xue, Lingling;
- Rosenberg, Elizabeth;
- Stein, Mark
Publication type:
Article
Phase I study of oral irinotecan as a single-agent and given sequentially with capecitabine.
Published in:
Investigational New Drugs, 2012, v. 30, n. 1, p. 290, doi. 10.1007/s10637-010-9528-x
By:
- Goff, Laura;
- Benson, Al;
- LoRusso, Patricia;
- Tan, Antoinette;
- Berlin, Jordan;
- Denis, Louis;
- Benner, Rebecca;
- Yin, Donghua;
- Rothenberg, Mace
Publication type:
Article
A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 5, p. 721, doi. 10.1007/s00280-022-04430-6
By:
- Manzo, Julia;
- Puhalla, Shannon;
- Pahuja, Shalu;
- Ding, Fei;
- Lin, Yan;
- Appleman, Leonard;
- Tawbi, Hussein;
- Stoller, Ronald;
- Lee, James J.;
- Diergaarde, Brenda;
- Kiesel, Brian F.;
- Yu, Jing;
- Tan, Antoinette R.;
- Belani, Chandra P.;
- Chew, Helen;
- Garcia, Agustin A.;
- Morgan, Robert J.;
- Wahner Hendrickson, Andrea E.;
- Visscher, Daniel W.;
- Hurley, Rachel M.
Publication type:
Article
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies.
Published in:
Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 1, p. 49, doi. 10.1007/s00280-021-04350-x
By:
- Tan, Antoinette R.;
- Chan, Nancy;
- Kiesel, Brian F.;
- Stein, Mark N.;
- Moss, Rebecca A.;
- Malhotra, Jyoti;
- Aisner, Joseph;
- Shah, Mansi;
- Gounder, Murugesan;
- Lin, Hongxia;
- Kane, Michael P.;
- Lin, Yong;
- Ji, Jiuping;
- Chen, Alice;
- Beumer, Jan H.;
- Mehnert, Janice M.
Publication type:
Article
Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.
Published in:
2020
By:
- Tolcher, Anthony W.;
- Kurzrock, Razelle;
- Valero, Vincente;
- Gonzalez, Rene;
- Heist, Rebecca S.;
- Tan, Antoinette R.;
- Means-Powell, Julie;
- Werner, Theresa L.;
- Becerra, Carlos;
- Wang, Chenxi;
- Leonowens, Cathrine;
- Kalyana-Sundaram, Shanker;
- Kleha, Joseph F.;
- Gauvin, Jennifer;
- D'Amelio, Anthony M.;
- Ellis, Catherine;
- Ibrahim, Nageatte;
- Yan, Li;
- D'Amelio, Anthony M Jr
Publication type:
journal article
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors.
Published in:
2019
By:
- Mehnert, Janice M.;
- Kaveney, Amanda D.;
- Malhotra, Jyoti;
- Spencer, Kristen;
- Portal, Daniella;
- Goodin, Susan;
- Tan, Antoinette R.;
- Aisner, Joseph;
- Moss, Rebecca A.;
- Lin, Hongxia;
- Bertino, Joseph R.;
- Gibbon, Darlene;
- Doyle, Laurence A.;
- White, Eileen P.;
- Stein, Mark N.
Publication type:
journal article
Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2‑positive breast cancer: an NSABP Foundation Research Program phase I study.
Published in:
2013
By:
- Jankowitz, Rachel C;
- Abraham, Jame;
- Tan, Antoinette R;
- Limentani, Steven A;
- Tierno, Marni B;
- Adamson, Laura M;
- Buyse, Marc;
- Wolmark, Norman;
- Jacobs, Samuel A
Publication type:
journal article
Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2-positive breast cancer: an NSABP Foundation Research Program phase I study.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1205, doi. 10.1007/s00280-013-2262-2
By:
- Jankowitz, Rachel C.;
- Abraham, Jame;
- Tan, Antoinette R.;
- Limentani, Steven A.;
- Tierno, Marni B.;
- Adamson, Laura M.;
- Buyse, Marc;
- Wolmark, Norman;
- Jacobs, Samuel A.
Publication type:
Article
Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 6, p. 1635, doi. 10.1007/s00280-013-2164-3
By:
- Tan, Antoinette;
- Gibbon, Darlene;
- Stein, Mark;
- Lindquist, Diana;
- Edenfield, Jeffery;
- Martin, Julie;
- Gregory, Charles;
- Suttle, A.;
- Tada, Hiroomi;
- Botbyl, Jeffrey;
- Stephenson, Joseph
Publication type:
Article
A randomized, double-blind, placebo-controlled study to evaluate the effect of repeated oral doses of pazopanib on cardiac conduction in patients with solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 565, doi. 10.1007/s00280-012-2030-8
By:
- Heath, Elisabeth;
- Infante, Jeffrey;
- Lewis, Lionel;
- Luu, Thehang;
- Stephenson, Joe;
- Tan, Antoinette;
- Kasubhai, Saifuddin;
- LoRusso, Patricia;
- Ma, Bo;
- Suttle, A.;
- Kleha, Joseph;
- Ball, Howard;
- Dar, Mohammed
Publication type:
Article
Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer.
Published in:
Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01475
By:
- Khoury, Katia;
- Tan, Antoinette R.;
- Elliott, Andrew;
- Xiu, Joanne;
- Gatalica, Zoran;
- Heeke, Arielle L.;
- Isaacs, Claudine;
- Pohlmann, Paula R.;
- Schwartzberg, Lee S.;
- Simon, Michael;
- Korn, W. Michael;
- Swain, Sandra M.;
- Lynce, Filipa
Publication type:
Article
ASO Visual Abstract: Does Residual Cancer Burden Predict Local Recurrence after Neoadjuvant Chemotherapy?
Published in:
2022
By:
- Pestana, Christine V.;
- Livasy, Chad A;
- Donahue, Erin E;
- Neelands, Brittany;
- Tan, Antoinette R.;
- Sarantou, Terry;
- Hadzikadic-Gusic, Lejla;
- White Jr., Richard L.
Publication type:
Abstract
Does Residual Cancer Burden Predict Local Recurrence After Neoadjuvant Chemotherapy?
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 12, p. 7716, doi. 10.1245/s10434-022-12038-6
By:
- Pestana, Christine V.;
- Livasy, Chad A.;
- Donahue, Erin E.;
- Neelands, Brittany;
- Tan, Antoinette R.;
- Sarantou, Terry;
- Hadzikadic-Gusic, Lejla;
- White Jr, Richard L.
Publication type:
Article
Molecular characterization of ESR1 variants in breast cancer.
Published in:
Breast Cancer Research & Treatment, 2022, v. 196, n. 2, p. 279, doi. 10.1007/s10549-022-06740-y
By:
- Heeke, Arielle L.;
- Elliott, Andrew;
- Feldman, Rebecca;
- O'Connor, Hazel F.;
- Pohlmann, Paula R.;
- Lynce, Filipa;
- Swain, Sandra M.;
- Nunes, Maria R.;
- Magee, Daniel;
- Oberley, Matthew J.;
- Swenson, Jeffrey;
- Vidal, Gregory;
- Isaacs, Claudine;
- Schwartzberg, Lee;
- Korn, W. Michael;
- Tan, Antoinette R.
Publication type:
Article
Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer.
Published in:
Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 377, doi. 10.1007/s10549-021-06143-5
By:
- Dent, Rebecca;
- Oliveira, Mafalda;
- Isakoff, Steven J.;
- Im, Seock-Ah;
- Espié, Marc;
- Blau, Sibel;
- Tan, Antoinette R.;
- Saura, Cristina;
- Wongchenko, Matthew J.;
- Xu, Na;
- Bradley, Denise;
- Reilly, Sarah-Jayne;
- Mani, Aruna;
- Kim, Sung-Bae;
- on behalf of the LOTUS investigators;
- Lee, K. S.;
- Sohn, J. H.;
- Kim, J. H.;
- Seo, J. H.;
- Kim, J. S.
Publication type:
Article
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway.
Published in:
Breast Cancer Research & Treatment, 2020, v. 184, n. 2, p. 265, doi. 10.1007/s10549-020-05849-2
By:
- Heeke, Arielle L.;
- Xiu, Joanne;
- Elliott, Andrew;
- Korn, W. Michael;
- Lynce, Filipa;
- Pohlmann, Paula R.;
- Isaacs, Claudine;
- Swain, Sandra M.;
- Vidal, Gregory;
- Schwartzberg, Lee S.;
- Tan, Antoinette R.
Publication type:
Article
A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer.
Published in:
Breast Cancer Research & Treatment, 2017, v. 165, n. 3, p. 601, doi. 10.1007/s10549-017-4375-5
By:
- Rugo, Hope;
- Trédan, Olivier;
- Ro, Jungsil;
- Morales, Serafin;
- Campone, Mario;
- Musolino, Antonino;
- Afonso, Noémia;
- Ferreira, Marta;
- Park, Kyong;
- Cortes, Javier;
- Tan, Antoinette;
- Blum, Joanne;
- Eaton, Lamar;
- Gause, Christine;
- Wang, Zhen;
- Im, Ellie;
- Mauro, David;
- Jones, Mary;
- Denker, Andrew;
- Baselga, José
Publication type:
Article
A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.
Published in:
Breast Cancer Research & Treatment, 2017, v. 163, n. 3, p. 535, doi. 10.1007/s10549-017-4199-3
By:
- Baselga, José;
- Morales, Serafin;
- Awada, Ahmad;
- Blum, Joanne;
- Tan, Antoinette;
- Ewertz, Marianne;
- Cortes, Javier;
- Moy, Beverly;
- Ruddy, Kathryn;
- Haddad, Tufia;
- Ciruelos, Eva;
- Vuylsteke, Peter;
- Ebbinghaus, Scot;
- Im, Ellie;
- Eaton, Lamar;
- Pathiraja, Kumudu;
- Gause, Christine;
- Mauro, David;
- Jones, Mary;
- Rugo, Hope
Publication type:
Article
Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9.
Published in:
Breast Cancer Research & Treatment, 2015, v. 152, n. 2, p. 399, doi. 10.1007/s10549-015-3466-4
By:
- Abraham, Jame;
- Robidoux, André;
- Tan, Antoinette;
- Limentani, Steven;
- Sturtz, Keren;
- Shalaby, Ibrahim;
- Alcorn, Hope;
- Buyse, Marc;
- Wolmark, Norman;
- Jacobs, Samuel
Publication type:
Article
Transforming growth factor-β signaling: emerging stem cell target in metastatic breast cancer?
Published in:
Breast Cancer Research & Treatment, 2009, v. 115, n. 3, p. 453, doi. 10.1007/s10549-008-0184-1
By:
- Tan, Antoinette;
- Alexe, Gabriela;
- Reiss, Michael
Publication type:
Article
Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008).
Published in:
Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 437, doi. 10.1007/s00262-015-1653-0
By:
- Lacouture, Mario;
- Morris, John;
- Lawrence, Donald;
- Tan, Antoinette;
- Olencki, Thomas;
- Shapiro, Geoffrey;
- Dezube, Bruce;
- Berzofsky, Jay;
- Hsu, Frank;
- Guitart, Joan
Publication type:
Article
Practical Guidance on Abemaciclib in Combination with Adjuvant Endocrine Therapy for Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative High-Risk Early Breast Cancer.
Published in:
Breast Cancer: Targets & Therapy, 2024, v. 16, p. 517, doi. 10.2147/BCTT.S271441
By:
- O'Keefe, Kaitlyn;
- Desai, Neelam V;
- Tan, Antoinette R
Publication type:
Article
Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data.
Published in:
Breast Cancer: Targets & Therapy, 2021, v. 13, p. 393, doi. 10.2147/BCTT.S176514
By:
- Jagosky, Megan;
- Tan, Antoinette R
Publication type:
Article
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma.
Published in:
PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0090353
By:
- Morris, John C.;
- Tan, Antoinette R.;
- Olencki, Thomas E.;
- Shapiro, Geoffrey I.;
- Dezube, Bruce J.;
- Reiss, Michael;
- Hsu, Frank J.;
- Berzofsky, Jay A.;
- Lawrence, Donald P.
Publication type:
Article